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S U M M A R Y
As the characteristics and accuracy of rapid inﬂuenza detection tests (RIDTs) vary, the development of a
high-performance RIDT has been eagerly anticipated. In this study, the new RIDT GOLD SIGN FLU and the
existing RIDT Quick Navi-Flu were evaluated in terms of detecting the antigens of inﬂuenza viruses A and
B in Japanese adults with inﬂuenza-like symptoms. The study was performed from December 2013 to
March 2014. Among the 123 patients from whom nasopharyngeal swab specimens were collected,
59 tested positive by viral isolation as the gold standard method (inﬂuenza A, n = 38; inﬂuenza B, n = 21).
For GOLD SIGN FLU, the sensitivities were 73.7% and 81.0%, and the speciﬁcities were 97.6% and 98.0% for
inﬂuenza A and B, respectively. For Quick Navi-Flu, the sensitivities were 86.8% and 85.7%, and the
speciﬁcities were 98.8% and 100% for inﬂuenza A and B, respectively. The time to the appearance of the
line on the test strip was less than 3 min for inﬂuenza A and less than 2 min for inﬂuenza B with both
RIDTs in more than 90% of cases. GOLD SIGN FLU was useful for diagnosing inﬂuenza A, and the result
was readily available for inﬂuenza B particularly among adult patients. Quick Navi-Flu showed better
sensitivities and speciﬁcities than GOLD SIGN FLU.
 2016 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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The inﬂuenza virus causes an acute respiratory infection and
can be transmitted easily from infected individuals to other people.
Inﬂuenza virus infection has a high morbidity and mortality among
pediatric patients, geriatric cases, and persons with chronic
medical conditions.1,2 Although treatment for inﬂuenza virus is
beneﬁcial in reducing the mortality of patients,3 people presenting
with fever and inﬂuenza-like symptoms may have several
differential diagnoses. Therefore, the accurate examination of
inﬂuenza virus infection cases has a very important role.
Additionally, making a rapid diagnosis of inﬂuenza virus infection
translates to reduced costs, better infection control, and appropri-
ate treatment .4,5
Reverse transcriptase PCR (RT-PCR) has a high sensitivity and a
high speciﬁcity for the rapid diagnosis of inﬂuenza infection.6
However, the high cost and necessity of specialized equipment have
limited the use of RT-PCR in the clinical setting. Instead,* Corresponding author. Tel.: +81 3 3342 6111; fax: +81 3 3349 6052.
E-mail address: osuishi@tokyo-med.ac.jp (Y. Akaishi).
http://dx.doi.org/10.1016/j.ijid.2016.10.002
1201-9712/ 2016 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).immunochromatography-based rapid inﬂuenza virus antigen tests,
in which the result appears within 15 min, have been used for the
early diagnosis of inﬂuenza in the clinical setting in Japan. Rapid
inﬂuenza detection tests (RIDTs) equipped with an instrument-
based ﬂuorescence reader system have recently been developed,
and their performances have been validated.7–9 However, the
detection sensitivities of these tests vary. Furthermore, RIDTs have a
lower sensitivity for type B inﬂuenza viruses than for type A
inﬂuenza viruses.10 Under these circumstances, the development of
a high-performance RIDT has long been anticipated.
In this study, the new RIDT GOLD SIGN FLU (Morinaga Milk
Industry Co., Ltd, Tokyo, Japan and Institute of Immunology Co.,
Ltd, Tokyo, Japan) and the existing immunochromatography-based
RIDT Quick Navi-Flu (Otsuka Pharmaceutical Co., Ltd, Tokyo, Japan)
were evaluated as compared to viral isolation as the gold standard
method.
2. Materials and Methods
The study protocol was reviewed and approved by the
Institutional Review Board of Tokyo Medical University.ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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Japanese adults with inﬂuenza-like symptoms were enrolled in
this study from December 2013 to March 2014. The study subjects
visited the outpatient clinics of the Department of Primary Care
and General Medicine at Tokyo Medical University Hospital.
Clinical data were collected using interview sheets and report
forms. Written informed consent to participate was obtained from
all participants.
A total of 123 participants were enrolled, consisting of 53 men
(43.1%) and 70 women (56.9%). The mean age of the patients was
35.1 years (range 20–74 years). The median time to visiting the
hospital after illness onset was 26.2 h (ranging from a few hours to
5 days; two patients failed to remember the time from illness
onset) (Table 1).
Nasopharyngeal swab specimens were collected by performing
original swab samplings, which were composed of three swabs.
Swab samples were collected from all participants. After collecting
the specimens from the participants, the swabs were separated for
the tests. One swab was transferred in viral transport medium (SRL
Co., Ltd, Tokyo, Japan) for virus isolation; the other two swabs were
used for the rapid inﬂuenza virus antigen detection tests.
2.2. Rapid inﬂuenza virus antigen detection test procedures
GOLD SIGN FLU and Quick Navi-Flu are immunochromato-
graphy-based rapid diagnostic tests with originally developed
mouse monoclonal inﬂuenza virus-speciﬁc antibodies. The
original antibody of GOLD SIGN FLU reacts with human-origin
inﬂuenza virus (subtypes H1N1, H2N2, H3N2, H5N1, and H7N9)
and animal-origin inﬂuenza virus (subtypes H1 to H15) in vitro.
The original antibody of Quick Navi-Flu reacts with human-origin
inﬂuenza virus (subtypes H1N1, H2N2, H3N2, and H5N1) and
animal-origin inﬂuenza virus (subtypes H1 to H16) in vitro. Based
on an immunochromatography method with these monoclonal
antibodies, GOLD SIGN FLU and Quick Navi-Flu display three lines:
one for the detection of inﬂuenza A, one for inﬂuenza B, and a
control.
GOLD SIGN FLU and Quick Navi-Flu were used in accordance
with the manufacturer’s instructions. The instructions state that
the time to result reading for GOLD SIGN FLU ranges from 1 to
8 min, whereas for Quick Navi-Flu this is 8 min. In the outpatient
clinic, these tests were performed simultaneously by one
laboratory technician who was contracted for this study. Further-
more, the laboratory technician recorded the time at which the line
appeared on the test strip within 30 min.
Samples for viral isolation were stored at 80 8C until the viral
isolation procedure.
2.3. Viral isolation
Frozen samples in viral transport medium were thawed and
centrifuged at 3000 rpm for 15 min, following which 300 ml ofTable 1
Characteristics of the study participants.
Characteristic Value
Total number 123
Sex, n (%)
Male 53 (43.1)
Female 70 (56.9)
Mean age 35.1 years (range: 20–74 years)
Median time to visiting hospital
from illness onseta
26.2 h (range: a few hours to 5 days)
a Two patients failed to remember the time from illness onset.each supernatant was inoculated on Madin–Darby canine kidney
(MDCK) cell monolayers in a 24-well plate (Thermo Fisher
Scientiﬁc Inc., , MA, USA). After 180 min of absorption at 33 8C,
each well was ﬁlled with Eagle’s minimum essential medium
(Thermo Fisher Scientiﬁc Inc., Waltham, MA, USA) containing 5%
fetal bovine serum, penicillin, streptomycin, amphotericin B, and
acetyl trypsin, and re-incubated at 33 8C. On the third day of viral
culture, subculture was performed and the cytopathic effect (CPE)
was monitored daily. When a CPE was observed, the supernatant
was harvested and virus infection was conﬁrmed by shell vial
culture centrifugation methods. When the CPE was not observed,
virus infection or non-infection was conﬁrmed by hemagglutina-
tion test.
2.4. Data analysis
True positive was deﬁned as viral isolation positive for
inﬂuenza A or B. The sensitivity, speciﬁcity, positive predictive
value (PPV), and negative predictive value (NPV) were calculated
using Excel software (Microsoft Corporation, Redmond, WA, USA).
3. Results
Among the 123 patients tested, 59 were found to be positive for
inﬂuenza A (n = 38) and B (n = 21) by viral isolation (Table 2).
3.1. Sensitivity and speciﬁcity
Comparing the GOLD SIGN FLU test with viral isolation as the
gold standard method, its sensitivities were 73.7% (28/38) and
81.0% (17/21), and its speciﬁcities were 97.6% (83/85) and 98.0%
(100/102) for inﬂuenza A and B, respectively.
Comparing the Quick Navi-Flu test with viral isolation as the
gold standard method, its sensitivities were 86.8% (33/38) and
85.7% (18/21), and its speciﬁcities were 98.8% (84/85) and 100%
(102/102) for inﬂuenza A and B, respectively.
3.2. PPVs and NPVs
For the GOLD SIGN FLU test, the PPVs for viral isolation were
93.3% (28/30) and 89.5% (17/19), and the NPVs for viral isolation
were 89.2% (83/93) and 96.2% (100/104) for inﬂuenza A and B,
respectively.
For the Quick Navi-Flu test, the PPVs for viral isolation were
97.1% (33/34) and 100% (18/18), and the NPVs for viral isolation
were 94.4% (84/89) and 97.1% (102/105) for inﬂuenza A and B,
respectively.
3.3. Detection times
More than 90% of the resulting lines appeared within less than
3 min for inﬂuenza A and less than 2 min for inﬂuenza B on the test
strips of both the GOLD SIGN FLU and Quick Navi-Flu tests.
4. Discussion
RIDTs have high sensitivities for samples from children.
Considering that many studies have been performed using samples
from children, the present study is valuable since adults were the
target population. The results showed that GOLD SIGN FLU has a
high sensitivity for inﬂuenza B among adults. It was also found that
Quick Navi-Flu has a higher sensitivity for inﬂuenza A and B than
GOLD SIGN FLU. The detection times for most of the samples with
both tests were less than 3 min, which is a very short time to obtain
diagnostic results.
Table 2
Performance of GOLD SIGN FLU and Quick Navi-Flu compared with viral isolation.
Rapid test Number of cases Sensitivity (%) Speciﬁcity (%) PPV (%) NPV (%)
Rapid test+ Rapid test+ Rapid test Rapid test
Isolation+ Isolation Isolation+ Isolation
GOLD SIGN FLU
Inﬂuenza A virus 28 2 10 83 73.7 97.6 93.3 89.2
Inﬂuenza B virus 17 2 4 100 81.0 98.0 89.5 96.2
Quick Navi-Flu
Inﬂuenza A virus 33 1 5 84 86.8 98.8 97.1 94.4
Inﬂuenza B virus 18 0 3 102 85.7 100 100 97.1
PPV, positive predictive value; NPV, negative predictive value.
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In previous studies, Booth et al. reported sensitivities of 80% and
47% by ImmunoCard STAT! and Binax NowFlu A & B for inﬂuenza A
and B among children and adults, respectively.10 Yoo et al. showed
sensitivities of 61.9% and 54.5% with the SD Bioline test for
inﬂuenza A and B among children and adults, respectively.11
Notably, Hurt et al. stated the absence of signiﬁcant differences in
the sensitivities among Binax Now Inﬂuenza A & B, Directigen EZ
Flu A + B, Denka Seiken Quick Ex-Flu, Fujirebio Espline Inﬂuenza
A&B-N, and Quidel QuickVue Inﬂuenza A + B Test. Hurt et al. found
that their sensitivities were 67–71% for inﬂuenza A among children
and adults.12 With regard to Espline Inﬂuenza A&B-N, a 91%
sensitivity for inﬂuenza A among only children was reported by De
Witte et al.13 For RIDTs equipped with an instrument-based
ﬂuorescence reader system, the BD Veritor system for inﬂuenza
A + B has been reported to have a sensitivity range of 72–93.8% for
inﬂuenza A and 69.3–94.2% for inﬂuenza B.7,8 On the other hand,
the Soﬁa Inﬂuenza A + B has been reported to have a 72.4%
sensitivity for inﬂuenza A among adults and a 95.8% sensitivity for
inﬂuenza A among children.8,9
4.2. Factors affecting sensitivity
Compared with the other detection tests, Espline Inﬂuenza
A&B-N, BD Veritor system for inﬂuenza A + B, and Soﬁa Inﬂuenza
A + B showed high sensitivities; however, the sensitivities were
considered to change according to the sampling type. Hurt et al.
and Chartrand et al. described a difference range of 14–19% in
sensitivity between child samples and adult samples.12,14 For adult
samples, inﬂuenza A (H1N1), inﬂuenza B, and sampling site have
been reported as factors that reduce sensitivity, because the viral
loads are considered to be lower in adults than in children, with
inﬂuenza A (H1N1) having a lower load than the other viral
types.14,15 Furthermore, nasopharyngeal samples obtained by
swabbing have a high sensitivity compared with nasal samples
obtained by swabbing and nasopharyngeal wash sampling.16
Moreover, the time of sample collection, the quality of the sample,
the characteristics of the kits, and the storage of the samples are
very important factors that affect sensitivity.
In this study, only adult samples were selected, and it was noted
that inﬂuenza A (H1N1) virus was in the epidemic status during the
2013–2014 season in Japan.17 Given these factors, the sensitivities
of GOLD SIGN FLU for inﬂuenza A and B would appear to be lower
than the other reported conditions.
4.3. Limitations
There are some limitations to this study. First, only adult
samples were used in this study. Thus, the usefulness of these tests
in children warrants clariﬁcation in future studies. Second, the
study period was the epidemic season of the inﬂuenza A (H1N1)virus. There is a need to verify test outcomes for other virus
subtypes in the future. Third, the relationship between viral load
and the RIDT is very important. If a RIDT reacts to a small viral load,
it will lead to an early-stage diagnosis. There is a need for future
veriﬁcation of the relationship between viral load and the new RIDT
GOLD SIGN FLU. Finally, samples from elderly people and people
with complications were limited. The sensitivities of the new RIDT
GOLD SIGN FLU for these populations also warrant veriﬁcation.
4.4. Conclusions
In this study, it was found that GOLD SIGN FLU is useful for
diagnosing inﬂuenza A and that the result was readily available for
inﬂuenza B particularly among adult patients. Quick Navi-Flu
showed better sensitivities and speciﬁcities than GOLD SIGN FLU.
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